{"url_path":"/sec/ibio/8-k/2026-05-08/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-08","source_url":"https://www.sec.gov/Archives/edgar/data/1420720/0001104659-26-057945-index.html","accession_number":"0001104659-26-057945","cik":"0001420720","ticker":"IBIO","issuer_name":"iBio, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1420720/0001104659-26-057945-index.html","primary_entity_key":"0001420720","primary_entity_name":"iBio, Inc."},"word_count":143,"has_tables":true,"body_markdown":"**Item 9.01.     Financial Statements and Exhibits.**\n\n​\n\n(d) Exhibits.\n\n​\n\nThe following exhibit is furnished with this Current Report on Form 8-K.\n\n​\n\n**Exhibit********Number**\n\n  ​ ​ ​\n\n**Exhibit Description**\n\n10.1\n\n​\n\n[Indemnification Agreement (Incorporated by reference as Exhibit 10.1 to the Current Report on Form 8-K filed with the Securities and Exchange Commission on April 1, 2019 - File No. 001-35023)](https://www.sec.gov/Archives/edgar/data/1420720/000114420419017417/tv517790_ex10-1.htm)\n\n99.1\n\n[Press Release, issued by iBio, Inc. dated May 8, 2026](ibio-20260507xex99d1.htm)\n\n104\n\n \n\nCover Page Interactive Data File (embedded within the Inline XBRL document)\n\n​\n\n​\n\n**SIGNATURES**\n\nPursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\nDate: May 8, 2026\n\n**IBIO, INC.**\n\n \n\n \n\n​\n\nBy: \n\n/s/ Marc A. Banjak\n\n \n\n \n\nName:\n\nMarc A. Banjak\n\n​\n\n​\n\nTitle:\n\nChief Legal Officer\n\n​\n\n​"}